Log in to access this content.
Amid Eli Lilly’s expanding legal fight with compounders and online peptide sellers marketing its experimental weight-loss drug retatrutide, FDA has sent another tranche of warning letters to five ...
The American Medical Association (AMA) is urging CMS to drop a proposal that would cut Medicare reimbursements for when a physician provides an office visit and a procedure to the same patient on the ...
The FDA is reiterating its claims that fluoropolymers, a subset of PFAS, in medical devices are safe, echoing industry arguments in a website update that the widely used chemicals are safer than other ...
While stakeholders are telling CMS to go back to the drawing board on its proposed state-directed payments rule, their concerns go way beyond the proposed expansion of the SDP cap to flag structural ...
The Trump administration's revamp of the 1115 waiver budget neutrality process will likely affect the 15 states with demonstrations set to expire in 2026, according to a Manatt analysis released this ...
States suing over the Medicaid work requirements interim final rule are narrowing their challenges to focus on alleged violations of the Administrative Procedure Act like the medically frail exemption ...
Medical associations are reiterating their recommendations that all adults and children over a certain age receive vaccinations against COVID-19, influenza and respiratory syncytial virus (RSV), which ...
As HHS and the Department of Justice continue to fight multiple court battles over an array of Trump administration health care policies, major cases over the Trump administration’s overhaul of CDC’s ...
The health insurance industry is highlighting a new Health Affairs analysis that finds the No Surprises Act’s independent dispute resolution process resulted in $22.4 billion in costs from 2022 to ...
As key Senate Democrats seek input on ways to design a public insurance option to cut health care costs, some prominent health care experts suggest a better way to improve federal health care ...
Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results